Cat: PA1000-8515

Recombinant Human NUMA1 Protein,His

  • Price
  • Size
  • Number

    Order now. For delivery time, please consult customer service

  • Pre-sale guidance and worry-free after-sale service
  • Quality assurance for cold chain transportation

Analytical Data

  • 基因名

    NUMA1

  • Application

    SPRMSTBLIITCELISA细胞实验药物筛选

  • 别名

    NUMA1;NMP22;NUMA;Nuclear mitotic apparatus Protein 1

  • 种属

    Human

  • 表达系统

    E. coli

  • 标签

    His tag N-Terminus

  • 纯度

    Greater than 90% as determined by SDS-PAGE.

  • 蛋白编号

    Q14980

  • 表达区间

    200-306aa

  • 氨基酸序列

    SPASPMGDILQTPQFQMRRLKKQLADERSNRDELELELAENRKLLTEKDA QIAMMQQRIDRLALLNEKQAASPLEPKELEELRDKNESLTMRLHETLKQC QDLKTEK

  • 分子量

    37 kDa

  • 内毒素

    < 1.0 EU per μg protein as determined by the LAL method.

  • 性状

    Freeze-dried powder

  • 缓冲液

    PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.

  • 复溶方法

    Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.

  • 个性化定制

    点位突变 标签定制 buffer定制 全长蛋白定制

  • 稳定性测试

    The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.

  • 保存条件 & 期限

    Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.

  • 运输条件

    In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.

Quality inspection process

Related Products

Protein Description

NUMA1 (Nuclear mitotic apparatus protein 1) is a crucial protein involved in the regulation of mitosis, specifically in the organization and positioning of the mitotic spindle. Its improper function is linked to various cellular processes, including cell division, apoptosis, and the maintenance of chromosomal integrity. Research has shown that NUMA1 interacts with various cellular components, such as microtubules and other spindle-related proteins, playing a vital role in ensuring accurate chromosome segregation during cell division. Dysregulation of NUMA1 expression or function has been implicated in several cancers, making it a significant focus for cancer research. Studies have reported that overexpression of NUMA1 can lead to tumor development and progression, while loss of function can result in genomic instability. Understanding the molecular mechanisms by which NUMA1 operates, as well as its potential as a therapeutic target, is of paramount importance. Advances in recombinant protein technology have facilitated the detailed study of NUMA1, allowing researchers to analyze its structure, function, and interactions within the cell. Through the production of recombinant NUMA1, scientists can investigate its roles in cell cycle regulation and explore potential applications in targeted therapies, aiming to manipulate its function for therapeutic benefit in cancer treatment and other diseases associated with cell division errors.


客服热线

027-8586 6806

E-mail

sales@ipodix.cn

人工客服①

汪经理

18007124176


加微信咨询

人工客服②

简经理

18164034885


加微信咨询
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
IPODIX North America (HQ)
Proteintech Group, Inc
5500 Pearl Street, Suite 400
Rosemont, IL 60018, USA
1-888-478-4522
proteintech@ptglab.com
  • 30000+

    Recombinant

  • 100+

    Researcher

  • 100+

    Countries Served

  • ISO

    Certified Quality

Committed to Quality
Driven by Innovation

Learn More About US